Clinical Efficacy and Safety of Supplementing Qi and Activating Blood Therapy for Heart Failure with Preserving Ejection Fraction and Qi Deficiency and Blood Stasis Syndrome: a Meta-analysis

Liu Jing; Xu Hao

doi:10.12102/j.issn.1672-1349.2018.11.002

Home>Articles>Clinical Efficacy and Safety of Supplementing Qi and Activating Blood Therapy for Heart Failure with Preserving Ejection Fraction and Qi Deficiency and Blood Stasis Syndrome: a Meta-analysis

DOI: 10.12102/j.issn.1672-1349.2018.11.002

Clinical Efficacy and Safety of Supplementing Qi and Activating Blood Therapy for Heart Failure with Preserving Ejection Fraction and Qi Deficiency and Blood Stasis Syndrome: a Meta-analysis

Liu Jing

Xu Hao

Machine-generated Keywords：

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 1476-1480 )

Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease

ISTIC

ISSN：1672-1349

Year, Vol.(Issue)：2018,16(11)